Department of Ophthalmology, Fudan University Eye and ENT Hospital, Shanghai 200031; Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Affiliated Hospital of Jiangnan University, Wuxi 214122, China.
Indian J Ophthalmol. 2023 Aug;71(8):2959-2961. doi: 10.4103/IJO.IJO_3186_22.
To evaluate the effect of extralesional triamcinolone acetonide (TA) injection in the treatment of small chalazion (diameter ≤ 5 mm).
Prospective interventional clinal study that included patients diagnosed as chalazion of small size not responding to conservative management for at least 2 weeks. All patients were treated with extralesional TA injection (4 mg). Successful resolution of a chalazion was defined as a decrease in size to 1 mm or smaller.
Thirty-eight patients were included in the study. The resolution was achieved in 33 (87%) patients. Nineteen (50%) patients had complete resolution after the first injection, and 13 (34.2%) patients had complete resolution after the second injection. Chalazion near the lower punctum needed more times of injections than those elsewhere (P = 0.02).
Extralesional TA injection is effective in the treatment of both primary and recurred small chalazia. It is a simple and cost-saving procedure and can be considered an alternative first-line treatment for small chalazion.
评估病变外曲安奈德（TA）注射治疗小睑板腺囊肿（直径≤5 毫米）的效果。
前瞻性干预性临床研究，纳入至少 2 周保守治疗后无反应的小睑板腺囊肿患者。所有患者均接受病变外 TA 注射（4 毫克）治疗。睑板腺囊肿成功消退定义为直径缩小至 1 毫米或更小。
共 38 例患者纳入研究。33 例（87%）患者消退。19 例（50%）患者首次注射后完全消退，13 例（34.2%）患者第二次注射后完全消退。下泪点附近的睑板腺囊肿需要更多次注射次数（P=0.02）。
病变外 TA 注射对原发性和复发性小睑板腺囊肿均有效。它是一种简单且节省成本的方法，可以考虑作为小睑板腺囊肿的一线替代治疗方法。
